Direct Reprogramming to Human Induced Neuronal Progenitors from Fibroblasts of Familial and Sporadic Parkinson’s Disease Patients

Minhyung LEE; Hyuna SIM; Hyunjun AHN; Jeongmin HA; Aruem BAEK; Young-Joo JEON; Mi-Young SON; Janghwan KIM.
International Journal of Stem Cells ; : 474-483, 2019.
Artículo en Inglés | WPRIM | ID: wpr-785826

Documentos relacionados

  1. Organ-Chips Enhance the Maturation of Human iPSC-Derived Dopamine Neurons.
  2. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
  3. CRISPR-Cas9-Edited SNCA Knockout Human Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons and Their Vulnerability to Neurotoxicity.
  4. Progress in direct reprogramming of dopaminergic cell replacement therapy.
  5. Multiomics analysis identifies novel facilitators of human dopaminergic neuron differentiation.
  6. Generation of human A9 dopaminergic pacemakers from induced pluripotent stem cells.
  7. Bioengineered models of Parkinson's disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment.
  8. Generation of integration-free Down syndrome and isogenic euploid human induced pluripotent stem cells.
  9. Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage.
  10. Induction of dopaminergic neurons for neuronal subtype-specific modeling of psychiatric disease risk.